Zions Reaches New 52-Week High (ZION)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- Zions (Nasdaq: ZION) hit a new 52-week high Wednesday as it is currently trading at $24.76, above its previous 52-week high of $24.57 with 2.4 million shares traded as of 3:41 p.m. ET. Average volume has been 2.6 million shares over the past 30 days.

Zions has a market cap of $4.46 billion and is part of the financial sector and banking industry. Shares are up 13.1% year to date as of the close of trading on Tuesday.

Zions Bancorporation, a bank and financial holding company, provides a range of banking and related services in the United States. The company has a P/E ratio of 24, above the S&P 500 P/E ratio of 17.7.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Zions as a hold. The company's strengths can be seen in multiple areas, such as its expanding profit margins, solid stock price performance and notable return on equity. However, as a counter to these strengths, we find that the growth in the company's net income has been quite unimpressive. You can view the full Zions Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.

null

More from Markets

Dow Trades Near 6 Month Low as Weak China Data Worries Wall Street

Dow Trades Near 6 Month Low as Weak China Data Worries Wall Street

Jim Cramer: I Can't Tell You to Buy This Market

Jim Cramer: I Can't Tell You to Buy This Market

The Brexit Breakdown: What American Investors Need to Know

The Brexit Breakdown: What American Investors Need to Know

Goldman Sachs Is a Leader in Underperformance - Here's How to Play It

Goldman Sachs Is a Leader in Underperformance - Here's How to Play It

Walgreens Slides on Downgrade From Goldman Sachs

Walgreens Slides on Downgrade From Goldman Sachs